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The aims of this study were to (1) record the changes of (arterial oxygen partial pressure) PaO,, (arterial carbon 
dioxide partial pressure) PaCO,, (percentage saturation of haemoglobin with oxygen in arterial blood) SaO, and 
alveolar-arterial (A-a) oxygen gradiant resulting from bronchoalveolar lavage (BAL) in asthmatic and normal 
subjects; (2) measure changes in forced expiratory volume in 1s (FEV,), vital capacity forced (FVC) associated with 
BAL; and (3) assess possible predictive factors for the degree of hypoxaemia and impairment of spirometry resulting 
from BAL. 
Bronchoscopy and BAL (150 ml) were performed in 24 asthmatics and 15 healthy subjects. Serial arterial blood 
samples (radial artery) were obtained in all subjects: T, and before T, after local anaesthesia; T, at end of 
bronchoscopy; T, after BAL and 5 min, 15 min, 1 h, 2 h, 8 h and 24 h (T,-T,,) after the procedure, FEV, and FVC 
were measured immediately before and 5 min afer bronchoscopy. 
Baseline PaO, was lower in asthmatics (10.2 f 0.8 kPa) than in healthy subjects (10.8 f 0.8). Both groups showed 
a significant decrease in PaO,, and a significant widening in (A-a) oxygen tension gradiant at TX-,, with respect to 
T, (WO.05). PaO, reached a significantly lower value in asthmatics (7.1 f 0.6 kPa) than in HS (7.7 f 0.5; PcO.05). 
In asthmatics, FEV,, FVC and the ratio FEV,/FVC decreased significantly after BAL (P<O.OOl). In healthy 
subjects, FEV, and FVC decreased significantly (P<O.OOl), whereas FEV,/FVC did not. The fall in FEV, after BAL 
was significantly greater in asthmatics (32.4 f 10~0%) than in healthy subjects (17.7 f 4.6; P<O.OOl). Severity of 
asthma, basline FEV, or initial PaO, did not predict the degree of hypoxaemia or the fall of FEV,. 
It is concluded that BAL causes more severe hypoxaemia and a greater decrease in FEV, in asthmatics compared 
to healthy subjects, strongly supporting the recommendation of special caution and careful monitoring when BAL 
is undertaken in asthmatics. 
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Introduction 
Fibre-optic bronchoscopy with bronchoalveolar lavage 
(BAL) is commonly used in the investigation of various 
pulmonary diseases (1,2). In recent years, BAL has been 
used increasingly to investigate the basic mechanisms of 
bronchial asthma, and numerous publications have been 
devoted to the use of bronchoscopy with BAL in asthmatic 
patients (3-8). 
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The safety of bronchoscopic procedures in the asthmatic 
patient has been a matter of obvious concern. Short-term 
reduction in pulmonary function (forced expiratory volume 
in 1 s = FEV,; forced vital capacity, FVC) has been demon- 
strated after the procedure (9-13). Some authors have 
suggested that bronchoconstriction is the principal mechan- 
ism causing a more marked fall in FEV, in asthmatic 
subjects (11); whereas others, in contrast, suggested a more 
restrictive reduction in lung function (13). Some investi- 
gators have found a more marked decrease in oxygen 
saturation in patients with mild asthma than in normal 
subjects (1 l), whereas others have shown no differences 
in BAL-associated desaturation between asthmatics’ and 
normal subjects (13). In these studies (11,13), using digital 
oximetry. oxygen saturation returned to normal soon after 
termination of the procedure. The analysis of arterial blood 
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TABLE 1. Subject characteristics: asthmatics and healthy subjects 
Number 
Age Sex 
(years) (male/female) 
Fev, 
(% predicted) 
FVC 
(% predicted) 
Asthmatics 24 58 f 10 18M/6F 79.1 & 16.3 94.0 + 10.4 
Healthy subjects 15 54* 12 3Ml12F 105.3 f 10.8 110.1 f 12.7 
gases represents a more precise technique for examining the 
effects of BAL on lung function. Moreover the analysis of 
arterial oxygen partial pressure (PaO,) and arterial carbon 
dioxide (PaCO,) gives information on the perfusion- 
ventilation relationship through the behaviour of alveolar 
arterial (A-a) oxygen tension gradient. To the authors’ 
knowledge, no studies have analysed the behaviour of 
arterial blood gases and (A-a) gradient associated with BAL 
in asthmatics, and monitored arteial blood gases for a 
period of up to 24 h after BAL. 
The aims of this study were to(l) record the changes of 
PaO,, PaCO, and (A-a) gradient resulting from BAL in 
asthmatics during and up to 24 h after the procedure; (2) 
measure changes in FEV, and FVC associated with BAL; 
and (3) assess possible predictive factors for the degree of 
hypoxaemia and impairment of spirometry resulting from 
BAL in asthmatics. 
Methods 
STUDY POPULATION 
Twenty-eight asthmatics were enrolled in the study. Two of 
them were excluded from data analysis because the endo- 
scopic procedure was suspended due to severe dyspnoea, 
and they were given inhaled salbutamol and intravenous 
theophylline. Two more subjects were excluded because it 
proved impractical to collect arterial blood sample. The 
data of 24 asthmatic subjects aged 58 * 10 years were 
analysed (Table 1). Asthma was defined according to the 
criteria of the American Thoracic Society (14). All subjects 
had a clinical history of intermittent wheeze, cough, chest 
tightness or dyspnoea, and documented reversible airway 
limitation either spontaneously or with treatment in the 
preceeding year. 
Subjects’ FEV, and FVC was, respectively, 79.1 k 16.3 
and 94.0 f 10.4, expressed as mean + SD of predicted value 
% (15). None of the subjects were current smokers and 
none had smoked within the previous 3 years. None of 
the subjects were taking oral steroids or long-acting 
&agonists. Nine subjects were taking inhaled steroids. The 
clinical severity of asthma was assessed according to the 
scoring system of Aas (16). Fifteen non-smoking subjects 
aged 54 f 12 years were studied (Table l), recruited from 
subjects who were referred to the asthma clinic for subjec- 
tive breathless or periodic cough and had negative investi- 
gations. They came to the laboratory on three occasions. 
On Day 1, spirometry, chest X-ray and peak expiratory 
flow (PEF) monitoring were performed and all subjects 
gave their written consent. On Day 2, methacoline chal- 
lenge was performed and 1 week later (Day 3), bron- 
choscopy was performed. No subject presented any 
respiratory symptom at the time of bronchial challenge or 
bronchoscopy. Mean FEV, was 1053 & 10.8 (% predicted), 
FEV was 110.1 & 12.7, and mean PEF daily variability 
(highest PEF - lowest PEF/highest PEF x 100) was <lo%, 
over a monitoring period of 2 weeks before the endoscopic 
procedure, using a Wright peak flow meter (Markos, 
Monza, Italy) (17). Provocative dose of methacholine for a 
20% fall in FEV, (PD& was ~1.5 mg in all healthy 
subjects. 
Bronchial challenge with methacholine was performed 
according to a method modified from the SEPCR working 
group guidelines to calculate the PD,, (15). The solutions 
were administered by nebulizer (Mefar MB3, Bavezzo, 
Brescia, Italy), and PD,, was calculated by interpolation. 
The study was approved by the Ethics Committee of 
Fondazione Salvatore Maugeri, and all subjects gave 
written informed consent. 
PULMONARY FUNCTION 
Pulmonary function was assessed with a dry wedge spirom- 
eter (Vitalograph, Buckinghamshire, U.K.) by measuring 
FEV, and FVC. At least three measurements were obtained 
and the values associated with the best FEV, were recorded 
by the same operator (PG). Spirometry was performed just 
before and 5 min after endoscopic procedure was com- 
pleted. /$ agonist (Salbutamol) was withheld for at least 8 h 
before testing. 
ENDOSCOPIC PROCEDURE 
Pre-medication consisted of intramuscular atropine 
(0.5 mg), intramuscular diazepam (5 mg) and local anaes- 
thesia with 2% lignocaine applied to the upper respiratory 
tract in all subjects. With the subjects in a supine position, 
an Olympus BFlT20 bronchoscope (Olympus Optical Co., 
Tokyo, Japan) was introduced through the mouth, and 1% 
lignocaine solution was administered through the broncho- 
scope channel to provide anaesthesia for the airways below 
the vocal cords. Duration of the procedure was timed from 
intubation of the vocal cords until extraction of the bron- 
choscope using an electric timer (Casio 376, ARW-320, 
Japan). The airways were systematically examined, the 
bronchoscope was wedged into one of the subsegmental 
bronchi of the middle lobe and BAL was performed using 
three aliquots of 50 ml saline pre-warmed at 37°C 
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re-aspirated by gentle 50 ml syringe suction by the same 
operator (PG) for all bronchoscopies. During bron- 
choscopy, oxygen, electrocardiographic monitoring and full 
resuscitation were readily available and the patient had an 
intravenous infusion to provide venous access. During the 
procedure, HbO, saturation was continuously monitored in 
all subjects using oxymetry (Pulsox 7-Minolta; AVL AG, 
SchaIIhausen, CH) with a finger probe. All subjects were 
given salbutamol 3OOpg by metered-dose inhaler, immedi- 
ately after the collection of arterial blood sample, 15 min 
after endoscopic procedure. Asthmatics restarted therapy 
that they were taking after the arterial blood gas analysis 
perfomed 8 h after the end of the endoscopic procedure. 
The protocol called for the procedure to be terminated 
if either the patient had severe asthma symptoms of 
HbO, saturation (monitored by oximetry) fell below 80%. 
In this case, oxygen would have been administered and 
bronchodilator therapy given. 
ARTERIAL BLOOD GAS ANALYSES 
Ten arterial blood samples were obtained for each subject 
at the following times (T): T, before and T, after local 
anaesthesia with 2% lignocaine; T, at end of routine 
bronchoscopy when the bronchoscope was wedged ready 
for BAL, T, at end of BAL with the bronchoscope still 
wedged, T, 5 min and T, 15 min after the end of the 
procedure; and T,, T,, T,, T,, (respectively) 1, 2, 8 and 24 h 
after the end of the procedure. All the arterial blood 
samples were obtained by the same operator (GBM) using 
a syringe (Microsample-AVL, Schaffausen, CH) with a 
thin needle (Microlance 256, 0.5 x 16, Dublin, Ireland). 
Arterial blood gas analyses were performed immediately on 
an ABL 330 (Radiometer, Copenhagen, Denmark) blood 
gas analyser situated in the same room where bronchoscopy 
was performed. 
PREDICTIVE FACTORS FOR HYPOXAEMIA 
AND IMPAIRMENT OF SPIROMETRY 
For the analysis of predictive factors, the authors correlated 
PaO, at time T,, basal FEV, measured before bron- 
choscopy and Aas score with the lowest value of PaO, 
occurring in asthmatics during the procedure, and the 
percentage fall in FEV, caused by the procedure. 
STATISTICAL ANALYSIS 
All the evaluated parameters were analysed by descriptive 
statistics. FEV, and FVC were expressed as a percentage of 
predicted value (15). SaO, as percentage, PaO,, PaCO, and 
(A-u) gradient are in kiloPascals (kPa). The distribution of 
the different parameters (FEV,; FVC; PaO,; PaCO,) was 
evaluated for normality using the Statgraphics Statistical 
Package, version 7. Since the data were normally distrib- 
uted, parametric tests were used. To detect differences 
concerning a variable measured at different times, ANOVA 
for repeated measurements was applied (multifactor 
ANOVA procedure of Statgraphics). Student’s t-test with 
Bonferroni correction was applied to detect significant 
changes in PaO,, PaCO,, SaO, and (A-a) gradient in the 
same subject (paired) or between two groups (unpaired). To 
detect differences concerning FEV,, FVC and FEV,/FVC 
in the same subjects, Student’s paired t- test was used. To 
evaluate the difference between groups, Student’s unpaired 
t-test was applied. Correlation coefficients, to study the 
association between two variables, were calculated by linear 
regression. A P value<0.05 was considered statistically 
significant. 
Results 
BAL FLUID RECOVERY AND DURATION OF 
THE PROCEDURE 
BAL fluid recovery was significantly lower at 56.6 & 11.0 ml 
in asthmatic patients compared with 73.0 5 13. ml in con- 
trols (P<O.OOl). Total duration of procedure did not differ 
in asthmatics (641 f 80 s) from that in healthy subjects 
(603.3 i 45.9 s) (J-+0.05). 
ARTERIAL BLOOD GASES 
PaO,, PaCO,, SaO, and (A-a) gradient values at the 
different times before, during and after the procedure are 
shown in Figs 1 and 2. A significant fall in PaO, was 
observed from T, to T,~-, in asthmatic and healthy subjects. 
The mean value of minimum PaO, values (7.10 f 0.60) 
reached in asthmatics (at T, or T,) was significantly lower 
than that in control subjects compared (7.75 * 0.47; 
P<O.O5). A significant fall in PaCO, was observed from T, 
to T, in asthmatic and healthy subjects. A significant 
increase in (A-cl) gradient was observed from T, to T,-, in 
asthmatic and healthy subjects. The width of (A-a) gradient 
was not significantly different between the two groups at 
different times (T,-T,,). There was no significant difference 
between the mean values of minimum PaO, reached during 
bronchoscopy in asthmatics treated with inhaled steroids 
(PaOz= 7.0 & 0.5) and asthmatics without inhaled steroids 
(Pa0,=7.2 f 0.6). 
PULMONARY FUNCTION 
In asthmatic patients, FVC decreased significantly from 
94.0 i 10.4 to 70.5 f 12.4% predicted (P<O.OOl), FEV, 
decreased significantly from 79.1 f 16.3 to 53.5 % 14.1% 
predicted (P<O.OOl) and the ratio FEV,/FVC decreased 
significantly from 68.0 * 9.8 to 61.5 f 10.1% (P<O.OOl; 
Fig. 1). In healthy subjects, FVC decreased significantly 
from 110.1 i 12.7 to 92.1 f 13.7% predicted (WO.001) 
and FEV, decreased significantly from 105.3 f IO.8 to 
86.2 f 10.0% predicted (P<O.OOl) with the procedure. 
However, the ratio FEV,/FVC did not change significantly 
from SO.2 i 6.6 to 78.7 & 7.7% (P>O.O5; Fig. 3). The fall in 
FEV, after the procedure was significantly higher in asth- 
matics than in healthy subjects (32.4 * 10.0 w 18.2 f 4.6%; 
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FIG. 1. Evolution of changes in PaO, (kPa) and SaO, 
(%) presented as mean f SD in asthmatics (AS, 0) and 
healthy subjects (HS, 0) at different times before, during 
and after the procedure. *Significant difference (PcO.05) 
when comparing values of the different times with respect 
to the value at baseline (T,). T, before and T, after local 
anaesthesia with lignocaine; T, at end of bronchoscopy; 
T, at end of BAL; T, 5 min and T, 15 min after the end 
of the procedure; T,-T,, (respectively) 1, 2, 8 and 24 h 
after the end of the procedure. 
P<O.OOl). The same was observed for FVC (24.9 * 11.0 vs 
16.5 & 5.9%; PcO.05). The fall in FEVr, expressed as 
percentage of the initial value, was significantly greater than 
the fall in FVC in asthmatics (P<O.OOl), whereas it did not 
differ significantly in healthy subjects (P>O.O5). There was 
no significant difference between the fall in either FEV, (%) 
or FVC (%) determined by the endoscopic procedure in 
asthmatics treated with inhaled steroids (FEViz33.1 * 8.8; 
FVC =23.2 * 11.2) and asthmatics without inhaled steroids 
(FEV, =32.0 f 10.9; FVC=26.0 jz 11.2). 
PREDICTIVE FACTORS FOR HYPOXEMIA AND 
IMPAIRMENT OF SPIROMETRY 
There was no significant correlation between the lowest 
value of PaO, reached in asthmatics during the procedure 
and PaO, at time T, (Y= -0.16) or basal FEV, (r=0.07) 
or Aas score (Y= - 0.04; P>O.O5). Similarly, there was 
no significant correlation between the same factors and 
the percentage fall in FEV, caused by the procedure in 
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FIG. 2. Evolution of changes in PaCO, and (4-u) 
gradient (kPa) presented as mean f SD in asthmatics 
(AS, 0) and healthy subjects (HS, 0) at different times 
before, during and after the procedure. *Significant 
difference (WO.05) when comparing values of the 
different times with respect to the value at baseline (T,). 
T, before and T, after local anaesthesia with lignocaine; 
T, at end of bronchoscopy; T, at end of BAL; T, 5 min 
and T, 15 min after the end of the procedure; T,-T,, 
(respectively) 1, 2, 8 and 24 h after the end of the 
procedure. 
asthmatics (PaO, at the time T,; r=0.29; basal FEV,: 
r=0.02; Aas score: rz0.03; P>O.O5). 
Discussion 
This study assessed the behaviour of PaO,, PaCO, and 
(A-a) gradient during and up to 24 h after BAL, and 
showed changes in FEV, and FVC caused by BAL in both 
asthmatics and healthy subjects. In addition, possible fac- 
tors predictive of the magnitude of 0, desaturation and 
impairment of spirometric values were assessed. There was 
a significant fall in PaO, and a significant widening of (A-a) 
gradient in both groups of subjects during and up to 8 h 
after the procedure. Asthmatics reached a significantly 
lower value of PaO,. PaCO, did not increase significantly 
at any time during the procedure. There was a decrease of 
FEV, and FVC after BAL in asthmatic and healthy sub- 
jects, but in asthmatics, the reduction in FEV, and FVC 
was significantly greater than in healthy subjects. In 
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FIG. 3. Evolution of changes in pulmonary function 
(FEV,; FVC; FEV,/FVC) before and after endoscopic 
procedure in asthmatic (0) and healthy (0) subjects. 
asthmatics, the magnitude of decrease of PaO, and FEV, 
was not predicted by the severity of asthma, baseline PaO, 
or basal FEV,. 
In the present study, a significant fall in PaO, was 
observed at the end of routine bronchoscopy (T3) and at 
end of BAL (TJ with respect to the value of PaO, at 
baseline (T,) in both asthmatic and healthy subjects. BAL 
was performed using three 50 ml aliquots of sterile saline, 
prewarmed at 37”C, without bronchial biopsies, &agonist 
pre-treatment and oxygen administration. The present 
results differ from those obtained by Djukanovic et al. (11) 
who performed BAL (eight 20 ml aliquots of saline pre- 
warmed to 37°C) and bronchial biopsies in asthmatics after 
albuteral and ipratropium bromide pre-medication and 
oxygen delivery during the procedure. They did not observe 
a significant decrease in oxygen saturation after BAL in 
asthmatic and normal subjects. Van Vyne et al. (13) per- 
formed BAL (five 50 ml aliquots of saline at room tempera- 
ture) and bronchial biopsies in asthmatics and normals 
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without bronchodilator pre-medication and oxygen deliv- 
ery. They demonstrated a significant decrease in oxygen 
saturation after BAL in asthmatic and normal subjects. The 
lack of oxygen administration in Van Vyne’s and the 
present study could explain the differences between those 
results and Djukanovic’s data. This observation is sup- 
ported by Dubrawsky’s study (18) in which patients with 
various pulmonary diseases, given supplemental oxygen, 
did not show a significant reduction in PaO,, while this 
occurred in patients who did not receive supplemental 
oxygen during two bronchial washes, totally 80 ml of 
normal saline at room temperature. In the present study, 
the minimum value of PaO, reached in asthmatics was 
significantly lower than that observed in healthy subjects. 
The authors can suggest the possible role played by the 
lower baseline value of PaO,, and lower fluid recovery 
observed in asthmatics. In fact, the difference in fluid 
recovery of asthmatics and healthy subjects might be one of 
the reasons determining different falls of PaO,, as suggested 
by Pirozynsky et al. (19). 
PaO, was significantly reduced 1, 2 and 8 h after the 
procedure, and at 5 and 15 min. In a previous study, Burns 
et al. (20) showed that healthy subjects lavaged with 
1000 ml of room temperature saline developed abnormali- 
ties in their ventilation-perfusion relationships, which per- 
sisted for 668 h after lobar lavage. This fact could explain 
the persisting significant decrease of PaO, until after 8 h of 
BAL in the present study. Moreover, the authors have 
found a significant widening of (A-a) gradient during and 
after BAL in asthmatic and healthy groups resulting in a 
reduction of efficiency of respiratory gases exchange, with a 
low ventilationperfusion ratio, still present 8 h after the 
procedure. This could be explained by ‘flooding’ of saline of 
bronchoalveolar spaces. 
The present study showed a significant fall in FEV, and 
FVC after the endoscopic procedure with BAL in asthmatic 
and healthy subjects in line with other studies (9,11,13) . 
Van Vyve et ul. found no change in FEV,IFVC ratio after 
the procedure in either asthmatics or control subjects, 
suggesting a more restrictive reduction in lung function. In 
the present study, all subjects experienced some restriction, 
demonstrated by a significant fall in FEV, and FVC in both 
asthmatics and healthy subjects. Moreover, a significant 
decrease in FEV,/FVC ratio was observed after BAL in 
asthmatics, whilst the ratio did not change in healthy 
subjects, suggesting a more obstructive reduction in lung 
function in asthmatics. This is emphasized by the more 
marked fall in FEV, in asthmatics. The more marked fall in 
FEV, in asthmatics may be related to the increased ten- 
dency (non-specific bronchial responsiveness) to broncho- 
constriction after lignocaine and forced expiratory 
manoeuvre, e.g. coughing (21) or physical stimulation by 
the bronchoscope and BAL. The present authors did not 
observe a significant correlation between the lowest value of 
PaO, in asthmatics and baseline FEV, or the clinical 
severity of asthma, characterized by the Aas core, as found 
in previous studies (11,13). Furthermore, it was found that 
baseline PaO, value cannot be considered a predictive 
factor for hypoxaemia determined by BAL. Previous 
studies have shown that arterial 0, desaturation is 
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dependent upon the volume of saline instilled (19,20) and 
the duration of the procedure (19) but in the present study, 
the volume of lavage was constant in all subjects and there 
was no great variation in the time required to complete the 
procedure in any of the subjects or between the two groups 
studied. In conclusion, this study has shown that: (i) BAL 
produces a significant reduction of PaO, and an increased 
width of (A-a) gradient, without increasing PaCO, during 
and up to 8 h after BAL in asthmatic subjects with asthma 
of variable severity; (ii) the extent and time course of 
reduction of PaO, and the increased width of (A-a) gradient 
are similar in asthmatics and healthy subjects, but asth- 
matics reach a significantly lower value of PaO,; (iii) the fall 
in FEV, and FVC after BAL is significantly greater in 
asthmatics than in healthy subjects; (iii) the fall in PaO, 
and FEV, cannot be predicted by the severity of asthma, 
baseline PaO, and FEV,. Although this study has con- 
firmed previous findings that BAL can be performed with- 
out &agonist, pre-medication and oxygen delivery during 
and after the procedure in asthmatics, the results have 
shown a significant decrease of PaO, lasting up to 8 h, a 
lower value of PaO, during the procedure and a mean 
reduction in FEV, of 32% demonstrating significant 
adverse effects which may not be apparent clinically. There- 
fore, the authors strongly support the recommendations of 
oxygen administration during bronchoscopy, and special 
caution and careful monitoring when BAL is undertaken 
in asthmatic subjects (22,23); additionally the authors 
recommend that oxygen saturation should be frequently 
monitored after the end of the procedure, and that pre- 
medication with &agonists should be administered before 
the endoscopic procedure in asthmatics. 
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